BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Wyeth (Richmond, VA) 

2248 Darbytown Road

Richmond  Virginia  23261  U.S.A.
Phone: n/a Fax:


SEARCH JOBS




At Wyeth, we have a vision of leading the way to a healthier world. We've committed ourselves to achieving this vision by making quality, integrity, and excellence the hallmarks of our business. Through recruitment, development, and motivation of the best people, we are continually growing and improving our business. We lead in innovation by linking pharmaceutical, biotechnology, and vaccine technologies.

The Richmond Wyeth Pharmaceutical and Wyeth Consumer Healthcare Facility consists of three separate sites totaling over 1.73 million square feet on 348 acres. Two sites, one manufacturing/office complex and the Wyeth Consumer Healthcare Global Research Complex, are all located near downtown Richmond. The other site, the Wyeth Pharmaceutical Complex and Distribution Center is located approximately six miles from downtown Richmond near the airport in Henrico County.

Located near downtown Richmond are the manufacturing/office complex and Pharmaceutical R & D. PR&D are the Wyeth Consumer Healthcare facilities. The PR&D group develops new formulations and supports/improves marketed formulations of Wyeth Consumer Healthcare products worldwide.

Our Darbytown complex was constructed in 1980 as a liquid manufacturing/packaging and dry products plant. In 1990, ChapStick manufacturing/packaging was added, followed by Denorex and Preparation H suppositories in 1995. The Richmond production capabilities include the manufacture and packaging of capsules, tablets, gels, creams, suppositories, tube products, and suspensions. In addition, Richmond is noted for the manufacturing and packaging of high-volume liquids. To support other product additions since 1990, numerous renovations have been made. These additions include renovations to the bulk manufacturing areas in 1997, a QA Annex in 2001, and a locker room and cafeteria in 2002.

This facility now consists of an administrative/lab/non-production area, a liquid-focused factory/pharmacy, a solids-focused factory, a topical-focused factory, and warehousing space.

Wyeth Pharmaceuticals is a leading pharmaceutical manufacturing facility in the Richmond tri-city and Tidewater area. Our highly efficient team manufactures such renowned products as Robitussin®, Dimetapp®, Children's Advil® and ChapStick®.

Each member of the Richmond organization is vital to the continuation of our organization's success. Our future achievements will rely on the balanced efforts of more than 1,400 employees.

Lead the way to a better career at Wyeth.
www.wyeth.com/careers

Last Updated: 11-14-03


 Key Statistics


Email:
Ownership: Public

Web Site: Wyeth (Richmond, VA)
Employees: 42,000 Worldwide
Symbol: WYE
 



Industry
Big Pharma

Segment
Research





 Company News
Wyeth (WYE) And Progenics Pharmaceuticals, Inc. (PGNX) Initiate Second Global Phase 3 Trial Of Intravenous Methylnaltrexone To Treat Post-operative Ileus 12/20/2006 3:21:14 PM    More...
Wyeth (WYE) Wins Philadelphia Phase II Diet Drug Cases 10/19/2005 5:13:15 PM    More...
Wyeth (WYE) Joins Nationwide Program To Assure Patient Access To Important Pharmaceutical Products 10/19/2005 5:13:14 PM    More...
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry 10/19/2005 5:13:07 PM    More...
Wyeth (WYE) To Present At The Smith Barney Citigroup Health Care Conference 10/19/2005 5:13:06 PM    More...
Wyeth (WYE) Release: National Institutes of Health (NIH) State-Of-The-Science Panel Supports Use Of Hormone Therapy For Treatment Of Moderate To Severe Menopausal Symptoms 10/19/2005 5:13:06 PM    More...
Wyeth (WYE) Comments On Earnings Guidance For 2005 First Quarter; Addresses Analyst Estimates 10/19/2005 5:13:05 PM    More...
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry 10/19/2005 5:13:05 PM    More...
Wyeth (WYE) Sets Webcast For Annual Meeting Of Stockholders 10/19/2005 5:13:02 PM    More...
Wyeth (WYE) Release: InductOs(TM) (rhBMP-2/ACS) Receives Additional European Commission Marketing Authorization 10/19/2005 5:13:02 PM    More...
12345